investorscraft@gmail.com

Intrinsic Value of Global Blood Therapeutics, Inc. (GBT)

Previous Close$0.00
Intrinsic Value
Upside potential
Previous Close
$0.00
* Our model cannot be used “out of the box” for the valuation of this stock. You can still do your own valuation by changing the valuation input parameters.

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2021-12-31 and quarterly data as of 2022-06-30.

  1. Annual
  2. Quarterly YoY
  3. Quarterly QoQ

Annual revenue growth rates, % (past and forecasted)

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year(a)2022202320242025202620272028202920302031203220332034203520362037203820392040204120422043204420452046

INCOME STATEMENT

Revenue growth rate, %57.3NaN
Revenue, $195NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $m482NaN
Operating income, $m-288NaN
EBITDA, $m-279NaN
Interest expense (income), $mNaN
Earnings before tax, $m-303NaN
Tax expense, $m0NaN
Net income, $m-303NaN

BALANCE SHEET

Cash and short-term investments, $m685NaN
Total assets, $m939NaN
Adjusted assets (=assets-cash), $m254NaN
Average production assets, $m36NaN
Working capital, $m714NaN
Total debt, $m586NaN
Total liabilities, $m743NaN
Total equity, $m196NaN
Debt-to-equity ratio2.984NaN
Adjusted equity ratio-1.896NaN

CASH FLOW

Net income, $m-303NaN
Depreciation, amort., depletion, $m9NaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $m-257NaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $m-3NaN
Free cash flow, $m-254NaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $m714
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount